RU2005100509A - Вакцинная композиция - Google Patents

Вакцинная композиция Download PDF

Info

Publication number
RU2005100509A
RU2005100509A RU2005100509/13A RU2005100509A RU2005100509A RU 2005100509 A RU2005100509 A RU 2005100509A RU 2005100509/13 A RU2005100509/13 A RU 2005100509/13A RU 2005100509 A RU2005100509 A RU 2005100509A RU 2005100509 A RU2005100509 A RU 2005100509A
Authority
RU
Russia
Prior art keywords
vesicular
pora
vesicle
strain
bactericidal activity
Prior art date
Application number
RU2005100509/13A
Other languages
English (en)
Russian (ru)
Inventor
МОРАЛЕС Рамон Фаустино БАРБЕРА (CU)
МОРАЛЕС Рамон Фаустино БАРБЕРА
Пьер Мишель ДЕМОН (BE)
Пьер Мишель ДЕМОН
АЛЬВАРЕС Франсиско Хесус ДОМИНГЕС (CU)
АЛЬВАРЕС Франсиско Хесус ДОМИНГЕС
Ян ПОЛМАН (BE)
Ян Полман
Original Assignee
Глаксосмитклайн Байолоджикалс С.А. (Be)
Глаксосмитклайн Байолоджикалс С.А.
Институто Финли, Сентро Де Инвестигасион-Продуксион Де Суэрос И Вакунас (Cu)
Институто Финли, Сентро Де Инвестигасион-Продуксион Де Суэрос И Вакунас
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Глаксосмитклайн Байолоджикалс С.А. (Be), Глаксосмитклайн Байолоджикалс С.А., Институто Финли, Сентро Де Инвестигасион-Продуксион Де Суэрос И Вакунас (Cu), Институто Финли, Сентро Де Инвестигасион-Продуксион Де Суэрос И Вакунас filed Critical Глаксосмитклайн Байолоджикалс С.А. (Be)
Publication of RU2005100509A publication Critical patent/RU2005100509A/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
RU2005100509/13A 2002-06-13 2003-06-10 Вакцинная композиция RU2005100509A (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0213622.4 2002-06-13
GBGB0213622.4A GB0213622D0 (en) 2002-06-13 2002-06-13 Vaccine Corporation

Publications (1)

Publication Number Publication Date
RU2005100509A true RU2005100509A (ru) 2006-06-10

Family

ID=9938532

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2005100509/13A RU2005100509A (ru) 2002-06-13 2003-06-10 Вакцинная композиция

Country Status (20)

Country Link
US (1) US20060110412A1 (enExample)
EP (1) EP1565211A2 (enExample)
JP (1) JP2005531614A (enExample)
KR (1) KR20050049431A (enExample)
CN (1) CN100387298C (enExample)
AR (1) AR040204A1 (enExample)
AU (1) AU2003236734A1 (enExample)
BR (1) BR0311777A (enExample)
CA (1) CA2488782A1 (enExample)
CL (1) CL2003001192A1 (enExample)
CU (1) CU23552A1 (enExample)
GB (1) GB0213622D0 (enExample)
MX (1) MXPA04012568A (enExample)
NO (1) NO20050132L (enExample)
NZ (1) NZ560766A (enExample)
PE (1) PE20040562A1 (enExample)
RU (1) RU2005100509A (enExample)
UY (1) UY27843A1 (enExample)
WO (1) WO2003105890A2 (enExample)
ZA (1) ZA200409547B (enExample)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030024811A (ko) 2000-07-27 2003-03-26 칠드런즈 하스피틀 앤드 리써치 센터 앳 오클랜드 나이세리아 메닌지티디스에 의하여 유발되는 질병에 대한광범위하게 유효한 보호를 위한 백신
GB2414667A (en) * 2004-06-03 2005-12-07 Isis Innovation Vaccine compositions of N. meningitidis PorA and FetA antigens
GB0419627D0 (en) * 2004-09-03 2004-10-06 Chiron Srl Immunogenic bacterial vesicles with outer membrane proteins
BRPI0607374B8 (pt) 2005-01-27 2021-05-25 Childrens Hospital & Res Center At Oakland vacinas de vesículas baseadas em gna1870 para proteção de amplo espectro contra doenças causadas por neisseria meningitidis
CA2808919C (en) * 2005-12-22 2016-04-19 Glaxosmithkline Biologicals S.A. Streptococcus pneumoniae capsular saccharide vaccine
SI2097102T1 (sl) 2006-09-07 2012-09-28 Glaxosmithkline Biolog Sa Kombinirano cepivo, ki ima zmanjšane količine antigena za poliovirus
CA2702871A1 (en) 2007-10-19 2009-04-23 Novartis Ag Meningococcal vaccine formulations
JP2011503104A (ja) 2007-11-09 2011-01-27 カリフォルニア インスティテュート オブ テクノロジー 免疫調節化合物ならびに関連組成物および方法
CN105044337A (zh) * 2008-02-01 2015-11-11 圣诺菲·帕斯图尔有限公司 用于诊断肺炎链球菌的试验
DK2268618T3 (en) 2008-03-03 2015-08-17 Novartis Ag Compounds and compositions as TLR aktivitetsmodulatorer
NZ593674A (en) 2008-12-17 2013-03-28 Novartis Ag Meningococcal vaccines including hemoglobin receptor
EP2440245B1 (en) 2009-06-10 2017-12-06 GlaxoSmithKline Biologicals SA Benzonaphthyridine-containing vaccines
AU2010288239B2 (en) 2009-08-27 2014-01-16 Novartis Ag Adjuvant comprising aluminium, oligonucleotide and polycation
SG178954A1 (en) 2009-09-02 2012-04-27 Novartis Ag Immunogenic compositions including tlr activity modulators
TWI445708B (zh) 2009-09-02 2014-07-21 Irm Llc 作為ｔｌｒ活性調節劑之化合物及組合物
EP2486940B1 (en) * 2009-10-08 2017-10-04 Aeon Medix Inc. Composition comprising extracellular membrane vesicles derived from indoor air, and use thereof
WO2011057148A1 (en) 2009-11-05 2011-05-12 Irm Llc Compounds and compositions as tlr-7 activity modulators
MX339146B (es) 2009-12-15 2016-05-13 Novartis Ag Suspension homogenea de compuestos inmunopotenciadores y usos de los mismos.
JP5894083B2 (ja) * 2009-12-22 2016-03-23 サノフィ パストゥール リミテッドＳａｎｏｆｉ Ｐａｓｔｅｕｒ Ｌｉｍｉｔｅｄ 免疫原性組成物
EP2547357A1 (en) 2010-03-18 2013-01-23 Novartis AG Adjuvanted vaccines for serogroup b meningococcus
EP2549990A1 (en) 2010-03-23 2013-01-30 Irm Llc Compounds (cystein based lipopeptides) and compositions as tlr2 agonists used for treating infections, inflammations, respiratory diseases etc.
WO2011127302A2 (en) * 2010-04-07 2011-10-13 Yue Shen Vehicle for delivering a compound to a mucous membrane and related compositions, methods and systems
US9259462B2 (en) * 2010-09-10 2016-02-16 Glaxosmithkline Biologicals Sa Developments in meningococcal outer membrane vesicles
EP2707009A1 (en) 2011-05-12 2014-03-19 Novartis AG Antipyretics to enhance tolerability of vesicle-based vaccines
EP2731617A4 (en) 2011-07-12 2015-07-01 Brigham & Womens Hospital LIPID-BASED PSA COMPOSITIONS, METHOD FOR THEIR INSULATION AND USE METHOD THEREFOR
ES2654613T3 (es) 2012-02-02 2018-02-14 Glaxosmithkline Biologicals Sa Promotores para una expresión aumentada de proteínas en meningococos
JP2015517089A (ja) 2012-03-08 2015-06-18 ノバルティス アーゲー タンパク質ベースの髄膜炎菌ワクチンのためのインビトロ有効性アッセイ
US10376573B2 (en) 2012-06-14 2019-08-13 Glaxosmithkline Biologicals Sa Vaccines for serogroup X meningococcus
AU2013311702A1 (en) 2012-09-06 2015-02-19 Novartis Ag Combination vaccines with serogroup B meningococcus and D/T/P
US11331335B2 (en) 2015-06-10 2022-05-17 California Institute Of Technology Sepsis treatment and related compositions methods and systems
EP3337321A4 (en) 2015-08-19 2019-07-17 President and Fellows of Harvard College LIPIDED PSA COMPOSITIONS AND METHOD
EP3484441A4 (en) 2016-07-15 2020-03-18 President and Fellows of Harvard College GLYCOLIPID COMPOSITIONS AND METHOD FOR USE
CA3035320A1 (en) 2016-09-02 2018-03-08 Glaxosmithkline Biologicals Sa Vaccines for neisseria gonorrhoeae
CA3166272A1 (en) * 2020-10-23 2022-04-28 Omvax, Inc. Compositions and methods for vaccination against neisseria gonorrhoeae
GB202115077D0 (en) 2021-10-21 2021-12-08 Glaxosmithkline Biologicals Sa Assay

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL338146A1 (en) * 1997-07-17 2000-09-25 North American Vaccine Immunogenic complex combinations consisting of meningococcal porine of b group and h. influenzae polysaccharide
GB9918319D0 (en) * 1999-08-03 1999-10-06 Smithkline Beecham Biolog Vaccine composition
KR20030024811A (ko) * 2000-07-27 2003-03-26 칠드런즈 하스피틀 앤드 리써치 센터 앳 오클랜드 나이세리아 메닌지티디스에 의하여 유발되는 질병에 대한광범위하게 유효한 보호를 위한 백신

Also Published As

Publication number Publication date
KR20050049431A (ko) 2005-05-25
MXPA04012568A (es) 2005-09-21
US20060110412A1 (en) 2006-05-25
WO2003105890A3 (en) 2004-03-25
CN1668329A (zh) 2005-09-14
NO20050132D0 (no) 2005-01-11
CN100387298C (zh) 2008-05-14
CU23552A1 (es) 2010-07-20
AU2003236734A1 (en) 2003-12-31
NZ560766A (en) 2009-09-25
GB0213622D0 (en) 2002-07-24
ZA200409547B (en) 2006-07-26
CA2488782A1 (en) 2003-12-24
BR0311777A (pt) 2005-03-29
CL2003001192A1 (es) 2005-01-07
PE20040562A1 (es) 2004-10-19
AR040204A1 (es) 2005-03-16
UY27843A1 (es) 2003-12-31
NO20050132L (no) 2005-02-11
WO2003105890A2 (en) 2003-12-24
JP2005531614A (ja) 2005-10-20
EP1565211A2 (en) 2005-08-24

Similar Documents

Publication Publication Date Title
RU2005100509A (ru) Вакцинная композиция
JP2005531614A5 (enExample)
JP4827726B2 (ja) 複数の髄膜炎菌血清群に対する注射可能ワクチン
JP6077983B2 (ja) 外膜タンパク質を有する免疫原性細菌小胞
JP4740738B2 (ja) ワクチン
RU2432962C2 (ru) Вакцины с использованием везикул на основе gna 1870 широкого спектра действия для профилактики заболеваний, вызываемых neisseria meningitidis
BE1022878B1 (fr) Vaccins anti-meningococciques
RU2015139827A (ru) МЕНИНГОКОККОВЫЕ ПОЛИПЕПТИДЫ fHBP
JP2012512240A (ja) ヘモグロビン受容体を含む髄膜炎菌ワクチン
JP2011105777A (ja) タンパク質を使用する髄膜炎菌の血清群ｙに対する免疫
EP2348036A3 (en) Novel immunogenic compositions for the prevention and treatment of meningococcal disease
JP2006503822A (ja) 改良された細菌外膜小胞
JP2005506322A (ja) Ｈｅｌｉｃｏｂａｃｔｅｒｐｙｌｏｒｉワクチン接種
RU2010153658A (ru) Мультивалентная вакцина из нативных везикул наружной мембраны менингококков, способы ее получения и применения
CN1901935A (zh) 具有改进耐受性的免疫原组合物中的疏水性蛋白调配物
ITMI20111182A1 (it) Vaccino per coronavirus canino
US20240226259A9 (en) Periodontitis vaccine and related compositions and methods of use
JP2017536823A (ja) 髄膜炎ｂワクチン
US20220204570A1 (en) Cra4s1 gene, encoded cra4s1 protein, and application
RU2364418C2 (ru) ВАКЦИННЫЕ КОМПОЗИЦИИ, СОДЕРЖАЩИЕ ЛИПОПОЛИСАХАРИДЫ ИММУНОТИПА L2 И/ИЛИ L3, ПРОИСХОДЯЩИЕ ИЗ ШТАММА NEISSERIA MENINGITIDIS IgtB-
WO2025017202A2 (en) Porphyromonas gingivalis antigenic constructs
Norheim et al. Prevention of serogroup A, C and W135 meningococcal disease in Africa with outer membrane vesicle vaccines
BR122025020594A2 (pt) Uso de uma composição imunogênica para induzir uma resposta imune, tratar ou prevenir uma infecção por neisseria meningitidis

Legal Events

Date Code Title Description
FA92 Acknowledgement of application withdrawn (lack of supplementary materials submitted)

Effective date: 20080114